Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Option Maestro (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Assumptions about liver transplant wait-list mortality challenged

% of readers think this story is Fact. Add your two cents.


Assumptions about liver transplant wait-list mortality challenged

By Kirsty Oswald, MedWire Reporter

06 August 2012

Gastroenterology 2012; Advance online publication

MedWireNews: The majority of liver patients who die on, or are removed from, the transplant wait-list have declined an offer of transplant, show the findings of an American study.

Patients who died or were delisted received a median of six offers during the 5-year study period, with 84% receiving at least one offer of a transplant. This is despite the fact that over half of them had received at least one offer of a high-quality liver.

The findings contradict the assumption that wait-list mortality is due to lack of opportunity for transplant, and instead may be heavily influenced by declined transplantation.

The study included 33,389 candidates for liver transplant who had a Model for End-Stage Liver Disease (MELD) score of at least 15 at the end of the study.

By the end of the study, 20% had died or became too sick for transplant, 64% had undergone transplant, and 10% were still awaiting transplant. Overall, the authors considered only 28% of transplanted livers as high-quality.

In patients without hepatocellular carcinoma, those who died or were delisted had lower median MELD scores at their first offer (17 vs 20) but spent a longer time on the wait-list (median: 230 vs 60 days) and received more offers than patients who underwent transplant (median: six vs four).

The majority of livers that were initially declined and subsequently transplanted in another patient were listed as being refused due to “donor quality/age.” Interestingly, 73% of high-quality livers were refused for this reason.

Additionally, when a high-quality liver was initially declined, the risk for graft failure with the subsequent transplant was similar to that seen when high-quality livers were accepted on the first offer.

The authors acknowledge that more detailed data are needed to fully understand why liver transplant offers are refused. However, they suggest that refusals could result from incomplete pre-transplantation workups, physician awareness and disclosure of donor-recipient relationships, and transplant center performance pressures.

John Roberts (University of California, San Francisco, USA) and colleagues say: “Simply increasing the availability of deceased donor livers or the number of offers may not substantially reduce wait-list mortality.”

They insist that further research is vital but suggest that patient education and changes to how transplant centers are assessed could help improve outcomes for patients.

The authors conclude: “Efforts should be made in the transplant community to reduce the stigma associated with non-ideal livers and set realistic expectations for wait-listed candidates.”
MedWire (www.medwire-news.md) is an independent clinical news service provided by Springer Healthcare Limited. © Springer Healthcare Ltd; 2012

Free abstract

http://www.medwire-news.md/41/100947/Gastroenterology/Assumptions_about_liver_transplant_wait-list_mortality_challenged.html


Source:


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

    Comments

    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    Total 1 comment
    • Roberto

      My name is Adrian, I have 33 years and I am from Romania, Bucharest, but I am with my job in Barcelona, Spain, and I live here.
      I have blood type, A2+ positive .. Height 1.80, weight 86 kg, I am healthy, with the analysis made in 2011. Apt, clinical to donate, lever lobe or kidney.
      I have a question about the status of donor kidneys.
      As Romanian citizen can I enroll in the program to search for possible candidate transplant for me in your hospital?!.
      Thank You.
      [email protected]

      Sincerely,
      Adrian Roberto, D.

    MOST RECENT
    Load more ...

    SignUp

    Login

    Newsletter

    Email this story
    Email this story

    If you really want to ban this commenter, please write down the reason:

    If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.